Project Details
Description
An Open-Label, Multicenter, Phase 2 Study to Evaluate Growth and Safety of LUM-201 Following 12 Months of Daily rhGH Treatment in Children with Idiopathic Growth Hormone Deficiency who have Previously Completed the LUM-201-01 Trial
| Status | Active |
|---|---|
| Effective start/end date | 5/15/23 → 6/16/28 |
Funding
- LUMOS PHARMA, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.